The effects of baseline length in Computed Tomography perfusion of liver

Abstract Objective: Computed Tomography perfusion (CTp) of liver is very attractive for predictive and prognostic purposes, but motion artefacts and radiation dose connected to duration of examinations jeopardize the reproducibility of perfusion values, thwarting CTp daily application in clinics. The goal is showing to what extent these issues can be faced by shortening the CTp unenhanced stage (i.e., the baseline). Methods: 59 patients with colorectal cancer underwent undelayed hepatic CTp examinations. For each patient, fifteen virtual examinations E τ simulating different scan delays τ ∈ [1..15] s were achieved from the undelayed original sequence E 0 . Absolute (AD), percentage (PD) and compound differences ( CD τ ) were computed between E 0  and each E τ for baseline and perfusion values and measured in HU and arbitrary units (a.u.), respectively. Patients were grouped and counted based on the differences achieved. Results: Maximum perfusion CD τ 10 a.u. and baseline CD τ 7 HU were achieved. For τ ≤ 10 s, maximum perfusion CD τ ∈ [5,6) a.u. was found in one patient only as well as maximum baseline CD τ ∈ [2,3) HU. Blood flow (BF), hepatic perfusion index and arterial BF showed the lowest CD τ , while portal BF and total BF the highest ones. PD is practically always higher than AD. Conclusion: The approach presented allows clinicians to design the shortest CTp acquisition protocol, selecting the highest delay compliant with the required accuracy for the chosen perfusion parameters, to limit patient’s motion and improve image quality. Significance: A short CTp protocol allows strengthening the reliability of perfusion values, and correctness of clinical outcomes, advancing CTp introduction in the standard clinical practice.

[1]  Apostolos Karantanas,et al.  Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps , 2018, Acta radiologica.

[2]  Jin Mo Goo,et al.  Quantitative Computed Tomography Imaging Biomarkers in the Diagnosis and Management of Lung Cancer , 2015, Investigative radiology.

[3]  Anastasia Bezerianos,et al.  Comparing Similarity Perception in Time Series Visualizations , 2019, IEEE Transactions on Visualization and Computer Graphics.

[4]  Massimo Mischi,et al.  Mathematical Models of Contrast Transport Kinetics for Cancer Diagnostic Imaging: A Review , 2016, IEEE Reviews in Biomedical Engineering.

[5]  Graham M. Treece The Bitonic Filter: Linear Filtering in an Edge-Preserving Morphological Framework , 2016, IEEE Transactions on Image Processing.

[6]  Yuko Nakamura,et al.  Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival. , 2018, European journal of radiology.

[7]  Arthur Tenenhaus,et al.  Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma? , 2018, European Radiology.

[8]  Agostino Gibaldi,et al.  Effects of guided random sampling of TCCs on blood flow values in CT perfusion studies of lung tumors. , 2015, Academic radiology.

[9]  Konstantin Nikolaou,et al.  Clinical applications for dual energy CT versus dynamic contrast enhanced CT in oncology. , 2015, European journal of radiology.

[10]  M. Maurin,et al.  REVIEW ARTICLE doi: 10.1111/j.1472-8206.2008.00633.x The Hill equation: a review of its capabilities in pharmacological modelling , 2008 .

[11]  Alessandro Bevilacqua,et al.  A novel approach for semi-quantitative assessment of reliability of blood flow values in DCE-CT perfusion , 2017, Biomed. Signal Process. Control..

[12]  G. Brix,et al.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  C. V. van Kuijk,et al.  Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities. , 2010, Ultrasound in medicine & biology.

[14]  Hiroshi Honda,et al.  Clinical application of radiation dose reduction for head and neck CT. , 2018, European Journal of Radiology.

[15]  Alessandro Bevilacqua,et al.  Automatic detection of misleading blood flow values in CT perfusion studies of lung cancer , 2016, Biomed. Signal Process. Control..

[16]  D. Hill,et al.  Non-rigid image registration: theory and practice. , 2004, The British journal of radiology.

[17]  Ting-Yim Lee Functional CT: physiological models , 2002 .

[18]  Ramsey D Badawi,et al.  CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates , 2018, European Radiology.

[19]  Tao Jiang,et al.  Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST) , 2012, Investigative radiology.

[20]  Y. Ohno,et al.  CT hepatic perfusion measurement: comparison of three analytic methods. , 2012, European journal of radiology.

[21]  A K Dixon,et al.  Functional images of hepatic perfusion obtained with dynamic CT. , 1993, Radiology.

[22]  Konstantin Nikolaou,et al.  Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis. , 2019 .

[23]  Lorenzo Faggioni,et al.  Is liver perfusion CT reproducible? A study on intra- and interobserver agreement of normal hepatic haemodynamic parameters obtained with two different software packages. , 2017, The British journal of radiology.

[24]  Torkel B. Brismar,et al.  Renal versus splenic maximum slope based perfusion CT modelling in patients with portal-hypertension , 2016, European Radiology.

[25]  Alessandro Bevilacqua,et al.  Liver CT perfusion: which is the relevant delay that reduces radiation dose and maintains diagnostic accuracy? , 2019, European Radiology.

[26]  N. Holalkere,et al.  Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. , 2007, Radiology.

[27]  David H. Kim,et al.  Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. , 2010, AJR. American journal of roentgenology.

[28]  Cynthia H McCollough,et al.  Evaluation of strategies to reduce radiation dose in perfusion CT imaging using a reproducible biologic phantom. , 2013, AJR. American journal of roentgenology.

[29]  Peter N. Burns,et al.  The prognostic and predictive value of vascular response parameters measured by dynamic contrast-enhanced-CT, -MRI and -US in patients with metastatic renal cell carcinoma receiving sunitinib , 2018, European Radiology.

[30]  Kostas Marias,et al.  Investigating the Correlation of Ktrans With Semi-Quantitative MRI Parameters Towards More Robust and Reproducible Perfusion Imaging Biomarkers in Three Cancer Types , 2019, IEEE Journal of Biomedical and Health Informatics.

[31]  Martin J Graves,et al.  A semi-automatic method for the extraction of the portal venous input function in quantitative dynamic contrast-enhanced CT of the liver. , 2017, The British journal of radiology.

[32]  Mark Parson,et al.  Perfusion Abnormalities are Frequently Detected by Early CT Perfusion and Predict Unfavourable Outcome Following Severe Traumatic Brain Injury , 2017, World Journal of Surgery.

[33]  Chaan S Ng,et al.  Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values. , 2013, Radiology.

[34]  Nathalie Lassau,et al.  Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. , 2013, European journal of radiology.

[35]  Tetsuya Kaneko,et al.  Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. , 2002, Journal of hepatology.

[36]  Alessandro Bevilacqua,et al.  Quantitative assessment of effects of motion compensation for liver and lung tumors in CT perfusion. , 2014, Academic radiology.

[37]  Ernst Klotz,et al.  Technical prerequisites and imaging protocols for CT perfusion imaging in oncology. , 2015, European journal of radiology.

[38]  Ernst Klotz,et al.  Correlation between Dual-Energy and Perfusion CT in Patients with Hepatocellular Carcinoma. , 2016, Radiology.

[39]  Naveen M. Kulkarni,et al.  Exploration of Imaging Biomarkers for Predicting Survival of Patients With Advanced Non-Small Cell Lung Cancer Treated With Antiangiogenic Chemotherapy. , 2016, AJR. American journal of roentgenology.

[40]  S Skornitzke,et al.  Qualitative and quantitative evaluation of rigid and deformable motion correction algorithms using dual-energy CT images in view of application to CT perfusion measurements in abdominal organs affected by breathing motion. , 2015, The British journal of radiology.

[41]  L. Loizou,et al.  Multi-detector CT: Liver protocol and recent developments. , 2017, European journal of radiology.

[42]  D Balvay,et al.  Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. , 2013, Diagnostic and interventional imaging.

[43]  Roberta Fusco,et al.  Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases , 2017, PloS one.

[44]  Hatem Alkadhi,et al.  CT Perfusion for Early Response Evaluation of Radiofrequency Ablation of Focal Liver Lesions: First Experience , 2016, CardioVascular and Interventional Radiology.

[45]  Rachida Lebtahi,et al.  Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. , 2017, The Lancet. Oncology.

[46]  B. V. Van Beers,et al.  Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. , 2000, Clinical science.

[47]  M. Ronot,et al.  CT and MR perfusion techniques to assess diffuse liver disease , 2019, Abdominal Radiology.

[48]  K. Bae,et al.  Intravenous contrast medium administration and scan timing at CT: considerations and approaches. , 2010, Radiology.